Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 1,415,566	$ 2,130,758
Accounts receivable, net of allowance for credit losses of $60,807 and $61,675, respectively	823,599	343,246
Inventory	218,076	243,285
Other current assets	577,150	341,311
Total current assets	3,034,391	3,058,600
Right of use asset	1,878,533	1,917,563
Property and equipment, net of accumulated depreciation of $798,034 and $760,655, respectively	797,471	799,538
Total assets	5,710,395	5,775,701
Current Liabilities:
Accounts payable	583,261	564,014
Accrued expenses	569,775	502,183
Corporate taxes payable	23,363	23,085
Right of use liability – current	338,810	323,935
Total current liabilities	1,515,209	1,413,217
Right of use liability - non-current	1,886,208	1,663,229
Derivative Liability	709,445	371,216
Total long-term liabilities	2,595,653	2,034,445
Total liabilities	4,110,862	3,447,662
Stockholders’ Equity
Preferred stock- authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock- authorized 190,000,000 shares, par value $0.001 par value; 5,646,118 and 4,858,663 shares issued and outstanding, as of March 31, 2026 and December 31, 2025, respectively	5,646	4,860
Additional Paid in Capital	15,068,955	12,583,193
Accumulated Deficit	(13,475,068)	(10,260,014)
Total Stockholders’ Equity	1,599,533	2,328,039
Total Liabilities and Stockholders’ Equity	$ 5,710,395	$ 5,775,701